Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Explore various investment strategies in the energy sector to boost your financial portfolio. Stay informed about trends and opportunities in this dynamic industry.
12,006 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
As Commvault shares dive, a fresh $19.8 million stake signals confidence from a hedge fund with a plan. Here's how to...
DoorDash sits near 52-week levels after a tough quarter that piled up costs from Deliveroo and grocery pushes. Yet Wa...
JPMorgan has begun a pilot that compares junior bankers' self-reported hours to computer activity, including keystrok...
As market conditions shift in 2026, debates over when to claim Social Security intensify. Suze Orman right about dela...
Evaxion's Q1 2026 results shed light on how its AI-driven drug discovery model is translating into collaborations and...
Investors noticed a notable move in jumia technologies stock jumped this week as Jumia reported improving early resul...
As HubSpot prepares to report its 2026 earnings, investors want clarity on growth drivers, profitability, and strateg...
Two durable, under-the-radar businesses outpaced the market for 10 years, underscoring the value of steady margins an...
A biotech insider sale can spark questions about company momentum. This article digs into the Stoke Therapeutics CMO ...
Investors are weighing Amazon's retail muscle against cloud and AI competition. This guide asks: could amazon actuall...
Bitcoin is gaining traction as a potential safe haven as geopolitical tensions heighten market nerves and gold funds ...